These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1725423)

  • 1. The biological activity of endothelin-1 analogues in three different assay systems.
    Watanabe TX; Itahara Y; Nakajima K; Kumagaye S; Kimura T; Sakakibara S
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S5-9. PubMed ID: 1725423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of endothelin: importance of charged groups.
    Nakajima K; Kubo S; Kumagaye S; Nishio H; Tsunemi M; Inui T; Kuroda H; Chino N; Watanabe TX; Kimura T
    Biochem Biophys Res Commun; 1989 Aug; 163(1):424-9. PubMed ID: 2673240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine scan of endothelin: importance of aromatic residues.
    Tam JP; Liu W; Zhang JW; Galantino M; Bertolero F; Cristiani C; Vaghi F; de Castiglione R
    Peptides; 1994; 15(4):703-8. PubMed ID: 7937349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of endothelin-1 analogues, endothelin-3, and sarafotoxin S6b: structure-activity relationships.
    Nakajima K; Kumagaye S; Nishio H; Kuroda H; Watanabe TX; Kobayashi Y; Tamaoki H; Kimura T; Sakakibara S
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S8-12; discussion S18. PubMed ID: 2473333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes.
    Battistini B; Germain M; Fournier A; Sirois P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S219-24. PubMed ID: 7509949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction.
    Spinella MJ; Malik AB; Everitt J; Andersen TT
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7443-6. PubMed ID: 1871142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.
    Doherty AM; Cody WL; He JX; DePue PL; Cheng XM; Welch KM; Flynn MA; Reynolds EE; LaDouceur DM; Davis LS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S98-102. PubMed ID: 7510009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
    J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the disulphide bonds in endothelin-1.
    Pelton JT; Miller RC
    J Pharm Pharmacol; 1991 Jan; 43(1):43-5. PubMed ID: 1676058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lys(-2)-Arg(-1)]endothelin-1 solution structure by two-dimensional 1H-NMR: possible involvement of electrostatic interactions in native disulfide bridge formation and in biological activity decrease.
    Aumelas A; Chiche L; Kubo S; Chino N; Tamaoki H; Kobayashi Y
    Biochemistry; 1995 Apr; 34(14):4546-61. PubMed ID: 7718556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.
    Douglas SA; Hiley CR
    Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship for ETB agonism in truncated endothelin-1 analogs.
    Saeki T; Ihara M; Fukuroda T; Yano M
    Biochem Int; 1992 Oct; 28(2):305-12. PubMed ID: 1456952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
    Kikuchi T; Kubo K; Ohtaki T; Suzuki N; Asami T; Shimamoto N; Wakimasu M; Fujino M
    J Med Chem; 1993 Dec; 36(25):4087-93. PubMed ID: 8258832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL; He JX; Reily MD; Haleen SJ; Walker DM; Reyner EL; Stewart BH; Doherty AM
    J Med Chem; 1997 Jul; 40(14):2228-40. PubMed ID: 9216842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity studies of the C-terminal region of the endothelins and the sarafotoxins.
    Doherty AM; Cody WL; Leitz NL; DePue PL; Taylor MD; Rapundalo ST; Hingorani GP; Major TC; Panek RL; Taylor DG
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S59-61. PubMed ID: 1725433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1.
    Kimura S; Kasuya Y; Sawamura T; Shinimi O; Sugita Y; Yanagisawa M; Goto K; Masaki T
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S5-7; discussion S18. PubMed ID: 2473327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity.
    Saeki T; Ihara M; Fukuroda T; Yamagiwa M; Yano M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):286-92. PubMed ID: 1652952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and biological activities of endothelin-1 analogs.
    Koshi T; Suzuki C; Arai K; Mizoguchi T; Torii T; Hirata M; Ohkuchi M; Okabe T
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):3061-3. PubMed ID: 1666025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and disulfide structure determination of porcine endothelin: an endothelium-derived vasoconstricting peptide.
    Kumagaye S; Kuroda H; Nakajima K; Watanabe TX; Kimura T; Masaki T; Sakakibara S
    Int J Pept Protein Res; 1988 Dec; 32(6):519-26. PubMed ID: 3073147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.